| 0.00% |
| 4 | DIMENSIONAL FUND ADVISORS LP | 2.1M | $53.4M | +2.1% | 5.347% | 0.01% |
| 5 | STATE STREET CORP | 2.1M | $52.3M | +7.3% | 5.237% | 0.00% |
| 6 | D. E. Shaw & Co., Inc. | 2.0M | $49.5M | -1.6% | 4.958% | 0.02% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 1.7M | $44.0M | -5.0% | 4.408% | 0.06% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $42.9M | -5.2% | 4.300% | 0.00% |
| 9 | GOLDMAN SACHS GROUP INC | 1.5M | $38.7M | -2.7% | 3.882% | 0.00% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $29.4M | +1.3% | 2.946% | 0.00% |
| 11 | MORGAN STANLEY | 1.1M | $29.0M | -17.8% | 2.910% | 0.00% |
| 12 | AMERICAN CENTURY COMPANIES INC | 1.0M | $25.8M | +21.6% | 2.588% | 0.01% |
| 13 | UBS Group AG | 920K | $23.3M | +63.7% | 2.339% | 0.00% |
| 14 | Impax Asset Management Group plc | 750K | $19.0M | 0.0% | 1.907% | 0.12% |
| 15 | TWO SIGMA INVESTMENTS, LP | 725K | $18.4M | +37.5% | 1.842% | 0.01% |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 691K | $17.5M | -5.6% | 1.756% | 0.00% |
| 17 | GAGNON SECURITIES LLC | 609K | $15.4M | -1.4% | 1.547% | 2.98% |
| 18 | WELLINGTON MANAGEMENT GROUP LLP | 563K | $14.3M | +17.8% | 1.432% | 0.00% |
| 19 | NORTHERN TRUST CORP | 527K | $13.4M | +1.4% | 1.339% | 0.00% |
| 20 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 411K | $10.4M | 0.0% | 1.046% | 0.18% |
| 21 | DEUTSCHE BANK AG\ | 391K | $9.9M | -0.1% | 0.994% | 0.00% |
| 22 | Jefferies Financial Group Inc. | 370K | $9.4M | +88.5% | 0.941% | 0.06% |
| 23 | Hillsdale Investment Management Inc. | 363K | $9.2M | +9.5% | 0.922% | 0.21% |
| 24 | Gagnon Advisors, LLC | 353K | $8.9M | 0.0% | 0.897% | 5.69% |
| 25 | JPMORGAN CHASE & CO | 347K | $8.7M | +44.2% | 0.881% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in PCRX — a direct measure of their conviction.
| 129.01% |
| 1.74 pp |
| $1.18B |
| +32% |
| Q4 2024 | 228 | 3.4% | 130.75% | 3.77 pp | $892M | +19% |
| Q3 2024 | 236 | — | 134.52% | — | $751M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
34 institutions opened new positions in PCRX during Q2 2026, while 24 fully exited. 169 added to existing positions and 44 trimmed.
PCRX institutional ownership fell by 0.85 percentage points quarter-over-quarter, with a net change of +13 holders.
The top 10 institutions account for 56.8% of all reported 13F value in PCRX, and the top 25 account for 78.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Pacira BioSciences, Inc. (PCRX) Institutional Ownership